Q: What are the overarching goals of the California Initiative to Advance Precision Medicine (CIAPM) and can you give us an idea of the types of demonstration projects you have undertaken? A: The goal of the Initiative is to maximize the use of the California’s enormous...
Q: Genomics, Digital Health, Big Data, and Artificial Intelligence are some of the newest technologies/fields that are reshaping medicine and healthcare. • How will these technologies impact healthcare and in particular individualized medicine? • What is it that...
Q: Once sequencing has been validated as a clinical solution via trusted workflows, and coinciding with the technological developments driving costs lower, we can expect accelerated human genome profiling for clinical Dx. How soon, do you think, will we see accelerated growth and what can...
Q: Genomics, Digital Health, Big Data, and Artificial Intelligence are some of the newest technologies/fields that are reshaping medicine and healthcare. • How will these technologies impact healthcare and in particular individualized medicine? • What is it that...
Q: Severe combined immunodeficiency (SCID) is characterized by severely impaired T-cell development and is fatal without treatment. What is the current treatment of infants identified as having SCID, and what is their likely clinical outcome if treated shortly after birth? A: • Overall, with improvements in...
Q: Genomics, Digital Health, Big Data, and Artificial Intelligence are some of the newest technologies/fields that are reshaping medicine and healthcare. How will these technologies impact healthcare and in particular individualized medicine? Are we there yet in terms of tangible impact, or is a good...
The field of precision medicine is moving forward in full speed. We are all witnessing it! Whether it is with the launch of various precision medicine/population sequencing studies, Or immunotherapy getting to be the new standard of care, and with it the potential for personally tailored treatments...
The field of precision medicine is moving forward in full speed. We are all witnessing it! Whether it is with the launch of various precision medicine/population sequencing studies, Or immunotherapy getting to be the new standard of care, and with it the potential for personally tailored treatments...
Q: What does your role entail as the director of the MolDX program at Palmetto GBA? A: The job directing MolDX is multifaceted; first and foremost the MolDX program is responsible for assessing molecular diagnostic tests on the market and makes coverage and pricing determinations for...
Q: The CBER’s Regenerative Medicine Advanced Therapy Designation program has been very successful, with about 100 requests for designation in the two years of its existence. Can you please tell us about the program and how it was put together? A: The Regenerative Medicine Advanced Therapy...
